Today is World Vitiligo Day, a global campaign dedicated to raising awareness, ending social stigma, and advocating for people living with vitiligo. Originally launched in 2011, the day unites the international community to promote research and support for those affected. At Thalocan Research Innovations Research Innovtions, we applaud the work of the GLOBAL VITILIGO FOUNDATION…
Thalocan Research Innovations Lesion Area Mapping Assistant (LAMA) was a HIT at the American Academy of Dermatology 2026 Annual meeting in Denver this past weekend. Many thanks to our COO, Cyrus Mirakhor for running such seamless and informative demonstrations. The Lesion Area Mapping Assistant is Thalocan’s cloud-based solution for enhancing lesion assessment in dermatologic clinical…
At SHSA 2025 in Nashville this past weekend, one of the primary topics discussed at our booth was the urgent needed for standardizing assessment for Hidradenitis Suppurativa. Being aware of the various ways that raters are CURRENTLY mapping lesions and how that process can be improved and standardized provided us with the roadmap we needed…
We are grateful to Dr. Steve Daveluy for his comments regarding trainings provided by Thalocan Research Innovations, including our Hidradenitis Suppurativa Clinical Trial training led by Dr. Amit Garg and Dr. John Ingram. You can view a portion of that here or learn about our other training curriculums by visiting www.thalocan.com/trainings
